SNOWFLAKE INC (5Q5.DE) Stock Fundamental Analysis

Europe • Frankfurt Stock Exchange • FRA:5Q5 • US8334451098

146.64 EUR
+3.92 (+2.75%)
Last: Feb 9, 2026, 07:00 PM
Fundamental Rating

4

Overall 5Q5 gets a fundamental rating of 4 out of 10. We evaluated 5Q5 against 74 industry peers in the IT Services industry. 5Q5 scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. 5Q5 is valued quite expensively, but it does show have an excellent growth rating.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

  • 5Q5 had positive earnings in the past year.
  • In the past year 5Q5 had a positive cash flow from operations.
  • 5Q5 had negative earnings in each of the past 5 years.
  • 5Q5 had a positive operating cash flow in 4 of the past 5 years.
5Q5.DE Yearly Net Income VS EBIT VS OCF VS FCF5Q5.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 0 500M -500M -1B

1.2 Ratios

  • 5Q5 has a worse Return On Assets (-16.40%) than 89.19% of its industry peers.
  • With a Return On Equity value of -63.27%, 5Q5 is not doing good in the industry: 86.49% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -16.4%
ROE -63.27%
ROIC N/A
ROA(3y)-11.57%
ROA(5y)-10.81%
ROE(3y)-24.53%
ROE(5y)-19.6%
ROIC(3y)N/A
ROIC(5y)N/A
5Q5.DE Yearly ROA, ROE, ROIC5Q5.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 -20 -40 -60 -80

1.3 Margins

  • With a Gross Margin value of 67.07%, 5Q5 perfoms like the industry average, outperforming 52.70% of the companies in the same industry.
  • 5Q5's Gross Margin has improved in the last couple of years.
  • 5Q5 does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 67.07%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.14%
GM growth 5Y3.51%
5Q5.DE Yearly Profit, Operating, Gross Margins5Q5.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025 0 50 -50 -100 -150

5

2. Health

2.1 Basic Checks

  • 5Q5 does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • 5Q5 has about the same amout of shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, 5Q5 has more shares outstanding
  • 5Q5 has a worse debt/assets ratio than last year.
5Q5.DE Yearly Shares Outstanding5Q5.DE Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
5Q5.DE Yearly Total Debt VS Total Assets5Q5.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

2.2 Solvency

  • 5Q5 has an Altman-Z score of 4.43. This indicates that 5Q5 is financially healthy and has little risk of bankruptcy at the moment.
  • The Altman-Z score of 5Q5 (4.43) is better than 86.49% of its industry peers.
  • 5Q5 has a debt to FCF ratio of 2.96. This is a good value and a sign of high solvency as 5Q5 would need 2.96 years to pay back of all of its debts.
  • 5Q5 has a Debt to FCF ratio (2.96) which is comparable to the rest of the industry.
  • 5Q5 has a Debt/Equity ratio of 1.07. This is a high value indicating a heavy dependency on external financing.
  • 5Q5 has a worse Debt to Equity ratio (1.07) than 67.57% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.07
Debt/FCF 2.96
Altman-Z 4.43
ROIC/WACCN/A
WACC9.19%
5Q5.DE Yearly LT Debt VS Equity VS FCF5Q5.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B 4B 5B

2.3 Liquidity

  • A Current Ratio of 1.37 indicates that 5Q5 should not have too much problems paying its short term obligations.
  • 5Q5 has a Current ratio of 1.37. This is in the better half of the industry: 5Q5 outperforms 60.81% of its industry peers.
  • 5Q5 has a Quick Ratio of 1.37. This is a normal value and indicates that 5Q5 is financially healthy and should not expect problems in meeting its short term obligations.
  • 5Q5 has a better Quick ratio (1.37) than 66.22% of its industry peers.
Industry RankSector Rank
Current Ratio 1.37
Quick Ratio 1.37
5Q5.DE Yearly Current Assets VS Current Liabilites5Q5.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B 5B

9

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 42.53% over the past year.
  • The Earnings Per Share has been growing by 334.45% on average over the past years. This is a very strong growth
  • The Revenue has grown by 28.48% in the past year. This is a very strong growth!
  • The Revenue has been growing by 68.78% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)42.53%
EPS 3Y334.45%
EPS 5YN/A
EPS Q2Q%75%
Revenue 1Y (TTM)28.48%
Revenue growth 3Y43.81%
Revenue growth 5Y68.78%
Sales Q2Q%28.75%

3.2 Future

  • Based on estimates for the next years, 5Q5 will show a very strong growth in Earnings Per Share. The EPS will grow by 41.25% on average per year.
  • The Revenue is expected to grow by 23.92% on average over the next years. This is a very strong growth
EPS Next Y50.18%
EPS Next 2Y42.45%
EPS Next 3Y41.11%
EPS Next 5Y41.25%
Revenue Next Year29.31%
Revenue Next 2Y26.72%
Revenue Next 3Y25.45%
Revenue Next 5Y23.92%

3.3 Evolution

  • Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
5Q5.DE Yearly Revenue VS Estimates5Q5.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 2034 5B 10B 15B 20B
5Q5.DE Yearly EPS VS Estimates5Q5.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 2034 0 5 10

1

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 141.00 indicates a quite expensive valuation of 5Q5.
  • Based on the Price/Earnings ratio, 5Q5 is valued a bit more expensive than 74.32% of the companies in the same industry.
  • 5Q5 is valuated expensively when we compare the Price/Earnings ratio to 28.06, which is the current average of the S&P500 Index.
  • With a Price/Forward Earnings ratio of 104.75, 5Q5 can be considered very expensive at the moment.
  • 5Q5's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. 5Q5 is more expensive than 74.32% of the companies in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 27.86, 5Q5 is valued quite expensively.
Industry RankSector Rank
PE 141
Fwd PE 104.75
5Q5.DE Price Earnings VS Forward Price Earnings5Q5.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100

4.2 Price Multiples

  • 5Q5's Price/Free Cash Flow ratio is a bit more expensive when compared to the industry. 5Q5 is more expensive than 71.62% of the companies in the same industry.
Industry RankSector Rank
P/FCF 76.75
EV/EBITDA N/A
5Q5.DE Per share data5Q5.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates 5Q5 does not grow enough to justify the current Price/Earnings ratio.
  • A more expensive valuation may be justified as 5Q5's earnings are expected to grow with 41.11% in the coming years.
PEG (NY)2.81
PEG (5Y)N/A
EPS Next 2Y42.45%
EPS Next 3Y41.11%

0

5. Dividend

5.1 Amount

  • No dividends for 5Q5!.
Industry RankSector Rank
Dividend Yield 0%

SNOWFLAKE INC

FRA:5Q5 (2/9/2026, 7:00:00 PM)

146.64

+3.92 (+2.75%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)12-03
Earnings (Next)02-25
Inst Owners73.59%
Inst Owner ChangeN/A
Ins Owners2.34%
Ins Owner ChangeN/A
Market Cap49.68B
Revenue(TTM)4.39B
Net Income(TTM)-1.35B
Analysts81.75
Price Target248.48 (69.45%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)19.9%
Min EPS beat(2)10.63%
Max EPS beat(2)29.18%
EPS beat(4)4
Avg EPS beat(4)29.73%
Min EPS beat(4)10.37%
Max EPS beat(4)68.73%
EPS beat(8)7
Avg EPS beat(8)28.63%
EPS beat(12)11
Avg EPS beat(12)66.06%
EPS beat(16)14
Avg EPS beat(16)111.07%
Revenue beat(2)2
Avg Revenue beat(2)1.9%
Min Revenue beat(2)0.66%
Max Revenue beat(2)3.15%
Revenue beat(4)4
Avg Revenue beat(4)1.62%
Min Revenue beat(4)0.66%
Max Revenue beat(4)3.15%
Revenue beat(8)8
Avg Revenue beat(8)1.61%
Revenue beat(12)11
Avg Revenue beat(12)1.2%
Revenue beat(16)15
Avg Revenue beat(16)1.34%
PT rev (1m)1.16%
PT rev (3m)5.08%
EPS NQ rev (1m)-0.53%
EPS NQ rev (3m)-9.31%
EPS NY rev (1m)-0.31%
EPS NY rev (3m)0.85%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.67%
Revenue NY rev (1m)-0.08%
Revenue NY rev (3m)0.98%
Valuation
Industry RankSector Rank
PE 141
Fwd PE 104.75
P/S 13.46
P/FCF 76.75
P/OCF 67.6
P/B 27.69
P/tB 84.19
EV/EBITDA N/A
EPS(TTM)1.04
EY0.71%
EPS(NY)1.4
Fwd EY0.95%
FCF(TTM)1.91
FCFY1.3%
OCF(TTM)2.17
OCFY1.48%
SpS10.89
BVpS5.3
TBVpS1.74
PEG (NY)2.81
PEG (5Y)N/A
Graham Number11.13
Profitability
Industry RankSector Rank
ROA -16.4%
ROE -63.27%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 67.07%
FCFM 17.54%
ROA(3y)-11.57%
ROA(5y)-10.81%
ROE(3y)-24.53%
ROE(5y)-19.6%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.14%
GM growth 5Y3.51%
F-Score4
Asset Turnover0.53
Health
Industry RankSector Rank
Debt/Equity 1.07
Debt/FCF 2.96
Debt/EBITDA N/A
Cap/Depr 49.21%
Cap/Sales 2.37%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.37
Quick Ratio 1.37
Altman-Z 4.43
F-Score4
WACC9.19%
ROIC/WACCN/A
Cap/Depr(3y)67.21%
Cap/Depr(5y)189.07%
Cap/Sales(3y)2.66%
Cap/Sales(5y)4.12%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)42.53%
EPS 3Y334.45%
EPS 5YN/A
EPS Q2Q%75%
EPS Next Y50.18%
EPS Next 2Y42.45%
EPS Next 3Y41.11%
EPS Next 5Y41.25%
Revenue 1Y (TTM)28.48%
Revenue growth 3Y43.81%
Revenue growth 5Y68.78%
Sales Q2Q%28.75%
Revenue Next Year29.31%
Revenue Next 2Y26.72%
Revenue Next 3Y25.45%
Revenue Next 5Y23.92%
EBIT growth 1Y-3.68%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year253.64%
EBIT Next 3Y83.66%
EBIT Next 5Y66.64%
FCF growth 1Y21.94%
FCF growth 3Y149.6%
FCF growth 5YN/A
OCF growth 1Y21.18%
OCF growth 3Y105.76%
OCF growth 5YN/A

SNOWFLAKE INC / 5Q5.DE FAQ

What is the fundamental rating for 5Q5 stock?

ChartMill assigns a fundamental rating of 4 / 10 to 5Q5.DE.


What is the valuation status for 5Q5 stock?

ChartMill assigns a valuation rating of 1 / 10 to SNOWFLAKE INC (5Q5.DE). This can be considered as Overvalued.


How profitable is SNOWFLAKE INC (5Q5.DE) stock?

SNOWFLAKE INC (5Q5.DE) has a profitability rating of 2 / 10.


What is the valuation of SNOWFLAKE INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for SNOWFLAKE INC (5Q5.DE) is 141 and the Price/Book (PB) ratio is 27.69.


What is the financial health of SNOWFLAKE INC (5Q5.DE) stock?

The financial health rating of SNOWFLAKE INC (5Q5.DE) is 5 / 10.